MiraLAX description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

MiraLAX

MSD Consumer Care, Inc.

MiraLAX


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredient (in each dose) (Bottle Only)

Polyethylene Glycol 3350, 17 g (cap filled to line)

Purpose

Osmotic Laxative

Active ingredient (in each dose) (Packet Only)

Polyethylene Glycol 3350, 17 g

Purpose

Osmotic Laxative

Use

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 1 to 3 days

Warnings

Allergy alert

Do not use if you are allergic to polyethylene glycol

Do not use if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • nausea, vomiting or abdominal pain
  • a sudden change in bowel habits that lasts over 2 weeks
  • irritable bowel syndrome

Ask a doctor of pharmacist before use if you are taking a prescription drug

When using this product you may have loose, watery, more frequent stools

Stop use and ask a doctor if

  • you have rectal bleeding or you nausea, bloating or cramping or abdominal pain gets worse. These may be signs of a serious condition.
  • you get diarrhea
  • you need to use a laxative for longer than 1 week

If pregnant or breast-feeding, ask a health professional before use.

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions (Bottle Only)

  • do not take more than directed unless advised by your doctor
  • the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)
  • adults and children 17 years of age and older:
    • fill to top of white section in cap which is marked to indicate the correct dose (17 g)
    • stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
    • use once a day
    • use no more than 7 days
  • children 16 years of age or under: ask a doctor

Directions (Packet Only)

  • do not take more than directed unless advised by your doctor
  • adults and children 17 years of age and older:
    • stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
    • use once a day
    • use no more than 7 days
  • children 16 years of age or under: ask a doctor

MiraLAX Other information

  • store at 20°-25°C (68°-77°F)
  • tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken

Inactive ingredients

none

Questions or comments?

1-800-MiraLAX (1-800-647-2529) or www.MiraLAX.com

Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA, a subsidiary of
Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 17 g × 10 Packet Carton

10
Packets

NDC 11523-7268-3

MiraLAX ®
Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

UNFLAVORED
POWDER
GRIT FREE

  • Relieves Occasional
    Constipation/Irregularity
  • Softens Stool

NeatPAX ®

10 ONCE-DAILY DOSES

10 PACKETS
NET WT 0.5 OZ (17g) EACH

MiraLAX

PRINCIPAL DISPLAY PANEL - 510 g Bottle Label

NDC 11523-7234-4

Original
Prescription
Strength

MiraLAX ®

Polyethylene Glycol 3350
Powder for Solution, Osmotic Laxative

  • Relieves Occasional
    Constipation (Irregularity)
  • Softens Stool

30
ONCE-DAILY
DOSES

NET WT 17.9 OZ (510 g)

MiraLAX

PRINCIPAL DISPLAY PANEL - 17 g × 3 Packet Carton

Trial
Pack

NDC 11523-7341-02

MiraLAX®
Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

UNFLAVORED
POWDER
GRIT FREE

  • Relieves Occasional
    Constipation/Irregularity
  • Softens Stool

NeatPAX®

3 ONCE-DAILY DOSES

3 PACKETS
NET WT 0.5 OZ (17g) EACH

MiraLAX

PRINCIPAL DISPLAY PANEL - Twin Pack - 765 g Bottle Label

Value
Size

NDC 11523-4357-1

MiraLAX®
Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

UNFLAVORED
POWDER
GRIT FREE

  • Relieves Occasional
    Constipation/Irregularity
  • Softens Stool

45 ONCE-DAILY DOSES
NET WT 26.9 OZ (765g)

32660-01

MiraLAX

MiraLAX

Polyethylene Glycol 3350 POWDER, FOR SOLUTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11523-7268
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
POLYETHYLENE GLYCOL 3350 17 g

Product Characteristics

Color
WHITE (Colorless upon dissolution)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 17 in 1 PACKET
2 17 in 1 PACKET
3 17 in 1 PACKET
4 NDC:11523-7268-4 765 in 1 BOTTLE, PLASTIC

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022015 2009-02-23


MiraLAX

Polyethylene Glycol 3350 POWDER, FOR SOLUTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11523-7234
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
POLYETHYLENE GLYCOL 3350 17 g

Product Characteristics

Color
WHITE (Colorless upon dissolution)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:11523-7234-1 17 in 1 PACKET
2 NDC:11523-7234-2 119 in 1 BOTTLE, PLASTIC
3 NDC:11523-7234-3 238 in 1 BOTTLE, PLASTIC
4 NDC:11523-7234-4 510 in 1 BOTTLE, PLASTIC
5 17 in 1 PACKET
6 NDC:11523-7234-6 17 in 1 PACKET
7 17 in 1 PACKET
8 17 in 1 PACKET
9 510 in 1 BOTTLE, PLASTIC
10 NDC:11523-7234-9 2 in 1 CELLO PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022015 2009-02-23


MiraLAX

Polyethylene Glycol 3350 POWDER, FOR SOLUTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11523-7341
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
POLYETHYLENE GLYCOL 3350 17 g

Product Characteristics

Color
WHITE (Colorless upon dissolution)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:11523-7341-1 612 in 1 BOTTLE, PLASTIC
2 17 in 1 PACKET
3 NDC:11523-7341-2 3 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022015 2009-02-23


MiraLAX

Polyethylene Glycol 3350 POWDER, FOR SOLUTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11523-4357
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
POLYETHYLENE GLYCOL 3350 17 g

Product Characteristics

Color
WHITE (colorless upon dissolution)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 765 in 1 BOTTLE, PLASTIC
2 NDC:11523-4357-1 2 in 1 PACKAGE, COMBINATION

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022015 2009-02-23


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.